Mudianto, Tenny

Dana-Farber Cancer Institute

2 papers on CoChatORCID 0000-0001-5314-2406

Most cited papers

Verified
Targeting EZH2 enhances antigen presentation, antitumor immunity, and circumvents anti-PD-1 resistance in head and neck cancer
Zhou, L., Mudianto, T., Ma, X., Riley, R., & Uppaluri, R. (2020) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 269
Verified
Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas
Mudianto, T., Campbell, K. M., Webb, J., Zolkind, P., Skidmore, Z. L., Riley, R., Barnell, E. K., Ozgenc, I., Giri, T., Dunn, G. P., et al. (2021) · Clinical Cancer Research
Hippo pathway signaling and YAP/TAZMelanoma and MAPK Pathways
Cited by 33

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free